Amifampridine is a voltage-gated potassium channel blocker. The mechanism by which amifampridine exerts its therapeutic effect in LEMS patients has not been fully elucidated.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Amifampridine is the active ingredient of these drugs:
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):